EDVINCE Trademark

Trademark Overview

On Wednesday, July 30, 2025, a trademark application was filed for EDVINCE with the United States Patent and Trademark Office. The USPTO has given the EDVINCE trademark a serial number of 79430938. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, March 3, 2026. This trademark is owned by Edvince AB. The EDVINCE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Scientific and technological services, namely, scientific research, in the field of developing methods for the treatment, prevention and alleviation of stroke; industrial analysis and research in the field of development methods for treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia; basic research and clinical research in the field of development of medicaments

Preparations for pharmaceutical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical preparations for pharmaceutical or medical purposes, namely, for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); diagnostic preparations for medical purposes for the treatment, prevention and alleviation of ischemic disor...
edvince

General Information

Serial Number79430938
Word MarkEDVINCE
Filing DateWednesday, July 30, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific and technological services, namely, scientific research, in the field of developing methods for the treatment, prevention and alleviation of stroke; industrial analysis and research in the field of development methods for treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia; basic research and clinical research in the field of development of medicaments
Goods and ServicesPreparations for pharmaceutical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical preparations for pharmaceutical or medical purposes, namely, for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); diagnostic preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical reagents for medical purposes; preparations for analysis for medical purposes, namely, for the treatment of ischemic disorders and diseases, stroke and subarachnoid hemorrhage and delayed cerebral ischemia (DCI)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 17, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEdvince AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events

Event DateEvent Description
Thursday, August 21, 2025SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, September 17, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, January 30, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 30, 2026APPLICATION FILING RECEIPT MAILED
Saturday, January 31, 2026ASSIGNED TO EXAMINER
Tuesday, March 3, 2026NON-FINAL ACTION WRITTEN
Wednesday, March 4, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Related Keywords

edvince treatment prevention alleviation ischemic stroke subarachnoid diseases hemorrhage purposes preparations